Loading…

Protective Activity of a Human Respiratory Syncytial Virus Immune Globulin Prepared from Donors Screened by Microneutralization Assay

To explore the feasibility of preparing a human immune globulin specific for respiratory syncytial virus (RSV) by screening plasma donors, the ability of seven RSV antibody assays to identify plasma-yielding IgG with high virus-neutralizing and animal-protective activities was compared. IgG prepared...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 1992-03, Vol.165 (3), p.456-463
Main Authors: Siber, George R., Leszczynski, Jeanne, Pena-Cruz, Victor, Ferren-Gardner, Carley, Anderson, Roger, Hemming, Val G., Walsh, Edward E., Burns, Jane, McIntosh, Kenneth, Gonin, Rene, Anderson, Larry J.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c414t-5fd2a4bbe7cebaf4ec436116799cbe185111a11d889108fd8a8124667cdfe8073
cites
container_end_page 463
container_issue 3
container_start_page 456
container_title The Journal of infectious diseases
container_volume 165
creator Siber, George R.
Leszczynski, Jeanne
Pena-Cruz, Victor
Ferren-Gardner, Carley
Anderson, Roger
Hemming, Val G.
Walsh, Edward E.
Burns, Jane
McIntosh, Kenneth
Gonin, Rene
Anderson, Larry J.
description To explore the feasibility of preparing a human immune globulin specific for respiratory syncytial virus (RSV) by screening plasma donors, the ability of seven RSV antibody assays to identify plasma-yielding IgG with high virus-neutralizing and animal-protective activities was compared. IgG prepared from plasma units selected by microneutralization assay had significantly higher activity in protecting mice from respiratory RSV challenge than did IgGs prepared from plasmas selected by three direct ELISAs using purified F protein, G protein, or RSV-infected cell lysate, by two competitive ELISAs with RSV neutralizing monoclonal antibodies directed to the F2 or F3 epitopes of the F protein, or by plaque reduction neutralization. Relative to IgG made from unselected plasma, microneutralization-screened IgG was enriched fivefold by plaque-reduction neutralization assays done with or without complement. The microneutralization assay identified RSV antibodies with highest animal protective activity. This assay will be useful for identifying plasma donors for the preparation of a human immune globulin with high protective activity against RSV and deserves further evaluation for prediction of protective antibody concentrations in children.
doi_str_mv 10.1093/infdis/165.3.456
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72816270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30112048</jstor_id><sourcerecordid>30112048</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-5fd2a4bbe7cebaf4ec436116799cbe185111a11d889108fd8a8124667cdfe8073</originalsourceid><addsrcrecordid>eNqFkUFv1DAUhCMEKkvhzgXJB8QtW7_YsZ3jaoHdiiKqFhDiYjmOI7kk9tZ2qoY7_xuvdmmPnEZ638xIT1MUrwEvATfkzLq-s_EMWL0kS1qzJ8UCasJLxoA8LRYYV1UJommeFy9ivMEYU8L4SXGSTQLqalH8uQw-GZ3snUGrvdg0I98jhbbTqBy6MnFng0o-zOh6dnpOVg3ouw1TROfjODmDNoNvp8E6dBnMTgXToT74Eb33zoeIrnUwxuVjO6PPVgfvzJSCGuxvlax3aBWjml8Wz3o1RPPqqKfFt48fvq635cWXzfl6dVFqCjSVdd9Virat4dq0qqdG53cAGG8a3RoQNQAogE6IBrDoO6EEVJQxrrveCMzJafHu0LsL_nYyMcnRRm2GQTnjpyh5JYBVHP_XCIwwRmBvxAdj_izGYHq5C3ZUYZaA5X4ieZgoJ2pJZJ4oR94cu6d2NN1j4LBJ5m-PXEWthj4op3PBPxulFeY1PNbcxLzOAyYYoMJUZF4euI3J3D9wFX5Jxgmv5fbHTynoJ8zXVxtJyF_Rx7W8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16366310</pqid></control><display><type>article</type><title>Protective Activity of a Human Respiratory Syncytial Virus Immune Globulin Prepared from Donors Screened by Microneutralization Assay</title><source>JSTOR Archival Journals and Primary Sources Collection【Remote access available】</source><source>Oxford University Press Archive</source><creator>Siber, George R. ; Leszczynski, Jeanne ; Pena-Cruz, Victor ; Ferren-Gardner, Carley ; Anderson, Roger ; Hemming, Val G. ; Walsh, Edward E. ; Burns, Jane ; McIntosh, Kenneth ; Gonin, Rene ; Anderson, Larry J.</creator><creatorcontrib>Siber, George R. ; Leszczynski, Jeanne ; Pena-Cruz, Victor ; Ferren-Gardner, Carley ; Anderson, Roger ; Hemming, Val G. ; Walsh, Edward E. ; Burns, Jane ; McIntosh, Kenneth ; Gonin, Rene ; Anderson, Larry J.</creatorcontrib><description>To explore the feasibility of preparing a human immune globulin specific for respiratory syncytial virus (RSV) by screening plasma donors, the ability of seven RSV antibody assays to identify plasma-yielding IgG with high virus-neutralizing and animal-protective activities was compared. IgG prepared from plasma units selected by microneutralization assay had significantly higher activity in protecting mice from respiratory RSV challenge than did IgGs prepared from plasmas selected by three direct ELISAs using purified F protein, G protein, or RSV-infected cell lysate, by two competitive ELISAs with RSV neutralizing monoclonal antibodies directed to the F2 or F3 epitopes of the F protein, or by plaque reduction neutralization. Relative to IgG made from unselected plasma, microneutralization-screened IgG was enriched fivefold by plaque-reduction neutralization assays done with or without complement. The microneutralization assay identified RSV antibodies with highest animal protective activity. This assay will be useful for identifying plasma donors for the preparation of a human immune globulin with high protective activity against RSV and deserves further evaluation for prediction of protective antibody concentrations in children.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/165.3.456</identifier><identifier>PMID: 1538152</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Animals ; Antibodies ; Biological and medical sciences ; Blood donation ; Blood Donors ; Disease Models, Animal ; Enzyme linked immunosorbent assay ; Human respiratory syncytial virus ; Humans ; Immunization, Passive ; Immunoglobulin G - blood ; Immunoglobulin G - therapeutic use ; Immunoglobulins ; Immunoglobulins, Intravenous - blood ; Immunoglobulins, Intravenous - therapeutic use ; Infections ; Infectious diseases ; Lung - microbiology ; Lungs ; Major Articles ; Medical sciences ; Mice ; Mice, Inbred BALB C ; Neutralization Tests ; respiratory syncytial virus ; Respiratory syncytial virus infections ; Respiratory syncytial viruses ; Respiratory Syncytial Viruses - immunology ; Respirovirus Infections - prevention &amp; control ; Viruses</subject><ispartof>The Journal of infectious diseases, 1992-03, Vol.165 (3), p.456-463</ispartof><rights>Copyright 1992 The University of Chicago</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-5fd2a4bbe7cebaf4ec436116799cbe185111a11d889108fd8a8124667cdfe8073</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30112048$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30112048$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4420751$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1538152$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Siber, George R.</creatorcontrib><creatorcontrib>Leszczynski, Jeanne</creatorcontrib><creatorcontrib>Pena-Cruz, Victor</creatorcontrib><creatorcontrib>Ferren-Gardner, Carley</creatorcontrib><creatorcontrib>Anderson, Roger</creatorcontrib><creatorcontrib>Hemming, Val G.</creatorcontrib><creatorcontrib>Walsh, Edward E.</creatorcontrib><creatorcontrib>Burns, Jane</creatorcontrib><creatorcontrib>McIntosh, Kenneth</creatorcontrib><creatorcontrib>Gonin, Rene</creatorcontrib><creatorcontrib>Anderson, Larry J.</creatorcontrib><title>Protective Activity of a Human Respiratory Syncytial Virus Immune Globulin Prepared from Donors Screened by Microneutralization Assay</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>To explore the feasibility of preparing a human immune globulin specific for respiratory syncytial virus (RSV) by screening plasma donors, the ability of seven RSV antibody assays to identify plasma-yielding IgG with high virus-neutralizing and animal-protective activities was compared. IgG prepared from plasma units selected by microneutralization assay had significantly higher activity in protecting mice from respiratory RSV challenge than did IgGs prepared from plasmas selected by three direct ELISAs using purified F protein, G protein, or RSV-infected cell lysate, by two competitive ELISAs with RSV neutralizing monoclonal antibodies directed to the F2 or F3 epitopes of the F protein, or by plaque reduction neutralization. Relative to IgG made from unselected plasma, microneutralization-screened IgG was enriched fivefold by plaque-reduction neutralization assays done with or without complement. The microneutralization assay identified RSV antibodies with highest animal protective activity. This assay will be useful for identifying plasma donors for the preparation of a human immune globulin with high protective activity against RSV and deserves further evaluation for prediction of protective antibody concentrations in children.</description><subject>Animals</subject><subject>Antibodies</subject><subject>Biological and medical sciences</subject><subject>Blood donation</subject><subject>Blood Donors</subject><subject>Disease Models, Animal</subject><subject>Enzyme linked immunosorbent assay</subject><subject>Human respiratory syncytial virus</subject><subject>Humans</subject><subject>Immunization, Passive</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin G - therapeutic use</subject><subject>Immunoglobulins</subject><subject>Immunoglobulins, Intravenous - blood</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Lung - microbiology</subject><subject>Lungs</subject><subject>Major Articles</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neutralization Tests</subject><subject>respiratory syncytial virus</subject><subject>Respiratory syncytial virus infections</subject><subject>Respiratory syncytial viruses</subject><subject>Respiratory Syncytial Viruses - immunology</subject><subject>Respirovirus Infections - prevention &amp; control</subject><subject>Viruses</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><recordid>eNqFkUFv1DAUhCMEKkvhzgXJB8QtW7_YsZ3jaoHdiiKqFhDiYjmOI7kk9tZ2qoY7_xuvdmmPnEZ638xIT1MUrwEvATfkzLq-s_EMWL0kS1qzJ8UCasJLxoA8LRYYV1UJommeFy9ivMEYU8L4SXGSTQLqalH8uQw-GZ3snUGrvdg0I98jhbbTqBy6MnFng0o-zOh6dnpOVg3ouw1TROfjODmDNoNvp8E6dBnMTgXToT74Eb33zoeIrnUwxuVjO6PPVgfvzJSCGuxvlax3aBWjml8Wz3o1RPPqqKfFt48fvq635cWXzfl6dVFqCjSVdd9Virat4dq0qqdG53cAGG8a3RoQNQAogE6IBrDoO6EEVJQxrrveCMzJafHu0LsL_nYyMcnRRm2GQTnjpyh5JYBVHP_XCIwwRmBvxAdj_izGYHq5C3ZUYZaA5X4ieZgoJ2pJZJ4oR94cu6d2NN1j4LBJ5m-PXEWthj4op3PBPxulFeY1PNbcxLzOAyYYoMJUZF4euI3J3D9wFX5Jxgmv5fbHTynoJ8zXVxtJyF_Rx7W8</recordid><startdate>19920301</startdate><enddate>19920301</enddate><creator>Siber, George R.</creator><creator>Leszczynski, Jeanne</creator><creator>Pena-Cruz, Victor</creator><creator>Ferren-Gardner, Carley</creator><creator>Anderson, Roger</creator><creator>Hemming, Val G.</creator><creator>Walsh, Edward E.</creator><creator>Burns, Jane</creator><creator>McIntosh, Kenneth</creator><creator>Gonin, Rene</creator><creator>Anderson, Larry J.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19920301</creationdate><title>Protective Activity of a Human Respiratory Syncytial Virus Immune Globulin Prepared from Donors Screened by Microneutralization Assay</title><author>Siber, George R. ; Leszczynski, Jeanne ; Pena-Cruz, Victor ; Ferren-Gardner, Carley ; Anderson, Roger ; Hemming, Val G. ; Walsh, Edward E. ; Burns, Jane ; McIntosh, Kenneth ; Gonin, Rene ; Anderson, Larry J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-5fd2a4bbe7cebaf4ec436116799cbe185111a11d889108fd8a8124667cdfe8073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Animals</topic><topic>Antibodies</topic><topic>Biological and medical sciences</topic><topic>Blood donation</topic><topic>Blood Donors</topic><topic>Disease Models, Animal</topic><topic>Enzyme linked immunosorbent assay</topic><topic>Human respiratory syncytial virus</topic><topic>Humans</topic><topic>Immunization, Passive</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin G - therapeutic use</topic><topic>Immunoglobulins</topic><topic>Immunoglobulins, Intravenous - blood</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Lung - microbiology</topic><topic>Lungs</topic><topic>Major Articles</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neutralization Tests</topic><topic>respiratory syncytial virus</topic><topic>Respiratory syncytial virus infections</topic><topic>Respiratory syncytial viruses</topic><topic>Respiratory Syncytial Viruses - immunology</topic><topic>Respirovirus Infections - prevention &amp; control</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Siber, George R.</creatorcontrib><creatorcontrib>Leszczynski, Jeanne</creatorcontrib><creatorcontrib>Pena-Cruz, Victor</creatorcontrib><creatorcontrib>Ferren-Gardner, Carley</creatorcontrib><creatorcontrib>Anderson, Roger</creatorcontrib><creatorcontrib>Hemming, Val G.</creatorcontrib><creatorcontrib>Walsh, Edward E.</creatorcontrib><creatorcontrib>Burns, Jane</creatorcontrib><creatorcontrib>McIntosh, Kenneth</creatorcontrib><creatorcontrib>Gonin, Rene</creatorcontrib><creatorcontrib>Anderson, Larry J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Siber, George R.</au><au>Leszczynski, Jeanne</au><au>Pena-Cruz, Victor</au><au>Ferren-Gardner, Carley</au><au>Anderson, Roger</au><au>Hemming, Val G.</au><au>Walsh, Edward E.</au><au>Burns, Jane</au><au>McIntosh, Kenneth</au><au>Gonin, Rene</au><au>Anderson, Larry J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protective Activity of a Human Respiratory Syncytial Virus Immune Globulin Prepared from Donors Screened by Microneutralization Assay</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1992-03-01</date><risdate>1992</risdate><volume>165</volume><issue>3</issue><spage>456</spage><epage>463</epage><pages>456-463</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>To explore the feasibility of preparing a human immune globulin specific for respiratory syncytial virus (RSV) by screening plasma donors, the ability of seven RSV antibody assays to identify plasma-yielding IgG with high virus-neutralizing and animal-protective activities was compared. IgG prepared from plasma units selected by microneutralization assay had significantly higher activity in protecting mice from respiratory RSV challenge than did IgGs prepared from plasmas selected by three direct ELISAs using purified F protein, G protein, or RSV-infected cell lysate, by two competitive ELISAs with RSV neutralizing monoclonal antibodies directed to the F2 or F3 epitopes of the F protein, or by plaque reduction neutralization. Relative to IgG made from unselected plasma, microneutralization-screened IgG was enriched fivefold by plaque-reduction neutralization assays done with or without complement. The microneutralization assay identified RSV antibodies with highest animal protective activity. This assay will be useful for identifying plasma donors for the preparation of a human immune globulin with high protective activity against RSV and deserves further evaluation for prediction of protective antibody concentrations in children.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>1538152</pmid><doi>10.1093/infdis/165.3.456</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1992-03, Vol.165 (3), p.456-463
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_72816270
source JSTOR Archival Journals and Primary Sources Collection【Remote access available】; Oxford University Press Archive
subjects Animals
Antibodies
Biological and medical sciences
Blood donation
Blood Donors
Disease Models, Animal
Enzyme linked immunosorbent assay
Human respiratory syncytial virus
Humans
Immunization, Passive
Immunoglobulin G - blood
Immunoglobulin G - therapeutic use
Immunoglobulins
Immunoglobulins, Intravenous - blood
Immunoglobulins, Intravenous - therapeutic use
Infections
Infectious diseases
Lung - microbiology
Lungs
Major Articles
Medical sciences
Mice
Mice, Inbred BALB C
Neutralization Tests
respiratory syncytial virus
Respiratory syncytial virus infections
Respiratory syncytial viruses
Respiratory Syncytial Viruses - immunology
Respirovirus Infections - prevention & control
Viruses
title Protective Activity of a Human Respiratory Syncytial Virus Immune Globulin Prepared from Donors Screened by Microneutralization Assay
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A20%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protective%20Activity%20of%20a%20Human%20Respiratory%20Syncytial%20Virus%20Immune%20Globulin%20Prepared%20from%20Donors%20Screened%20by%20Microneutralization%20Assay&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Siber,%20George%20R.&rft.date=1992-03-01&rft.volume=165&rft.issue=3&rft.spage=456&rft.epage=463&rft.pages=456-463&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/165.3.456&rft_dat=%3Cjstor_proqu%3E30112048%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c414t-5fd2a4bbe7cebaf4ec436116799cbe185111a11d889108fd8a8124667cdfe8073%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16366310&rft_id=info:pmid/1538152&rft_jstor_id=30112048&rfr_iscdi=true